Review
Models and mechanisms of acute lung injury caused by direct insults

https://doi.org/10.1016/j.ejcb.2011.11.004Get rights and content

Abstract

Acute lung injury (ALI) and its more severe form acute respiratory distress syndrome (ARDS) are life-threatening diseases that are characterized by acute onset, pulmonary inflammation, oedema due to increased vascular permeability and severe hypoxemia. Clinically, ARDS can be divided into ARDS due to direct causes such as pneumonia, aspiration or injurious ventilation, and due to extrapulmonary indirect causes such as sepsis, severe burns or pancreatitis. In order to identify potential therapeutic targets, we asked here whether common molecular mechanisms can be identified that are relevant in different models of the direct form of ALI/ARDS. To this end, we reviewed three widely used models: (a) one based on a biological insult, i.e. instillation of bacterial endotoxins; (b) one based on a chemical insult, i.e. instillation of acid; and (c) one based on a mechanical insult, i.e. injurious ventilation. Studies were included only if the mediator or mechanism of interest was studied in at least two of the three animal models listed above. As endpoints, we selected neutrophil sequestration, permeability, hypoxemia (physiological dysfunction) and survival. Our analysis showed that most studies have focused on mechanisms of pulmonary neutrophil sequestration and models with moderate forms of oedema. The underlying mechanisms that involve canonical inflammatory pathways such as MAP kinases, CXCR2 chemokines, PAF, leukotrienes, adhesions molecules (CD18, ICAM-1) and elastase have been defined relatively well. Further mechanisms including TNF, DARC, HMGB1, PARP, GADD45 and collagenase are under investigation. Such mechanisms that are shared between the three ALI models may represent viable therapeutic targets. However, only few studies have linked these pathways to hypoxemia, the most important clinical aspect of ALI/ARDS. Since moderate oedema does not necessarily lead to hypoxemia, we suggest that the clinical relevance of experimental studies can be further improved by putting greater emphasis on gas exchange.

Introduction

Acute lung injury (ALI) is a life threatening condition with an incidence in the United States of 79 per 100,000 and an overall mortality that is comparable to the number of deaths attributed to breast cancer (Rubenfeld et al., 2005). The diagnosis for ARDS is based on those four well known criteria defined by the American-European Consensus Conference for Acute Respiratory Distress Syndrome (ARDS) in 1994 (see Table 1). These criteria reflect the underlying pathophysiology and the severity of the disease: (i) ALI is an acute, not a chronic disease. (ii) The bilateral infiltrates on chest radiographs indicate pulmonary inflammation caused by leukocyte infiltration and plasma exudation. (iii) The pulmonary wedge pressure cut-off emphasizes that the exudate is of inflammatory nature and not caused by increased hydrostatic pressure; in fact, increased vascular permeability is considered a hallmark of ARDS. (iv) To be called ARDS, the inflammation must be sufficiently severe and lead to hypoxemia: if PaO2:FiO2 < 300 mmHg, it is called Acute Lung Injury (ALI), if PaO2:FiO2 < 200 mmHg Acute Respiratory Distress Syndrome (ARDS). At present, therapy for ARDS is largely supportive and only one phase III trial has ever shown a beneficial effect on the mortality of this disease (ARDSNet, 2000). In addition to defining ARDS, the American-European Consensus Conference distinguished pulmonary ARDS, caused by insults directly affecting the lung parenchyma, e.g. pneumonia, gastric aspiration or inhalation, from extra-pulmonary ARDS, resulting from an acute systemic inflammatory response (Bernard et al., 1994). Clinically, direct ARDS is characterized by a stronger increase in lung elastance and appears more resistant to therapeutical interventions, e.g. PEEP, prone positioning or recruitment manoeuvres than indirect ARDS (Pelosi et al., 2001).

At present, therapy for ARDS is largely supportive and novel treatment options are urgently needed. Therefore, this is a highly active area of research and considerable progress has been made towards understanding the molecular mechanisms of pulmonary inflammation and ALI. Obviously, ALI involves a complex process and the pathomechanisms depend to some degree on the model studied. On the other hand, in the clinical situation ALI is embraced as one common entity independent of its aetiologies. Hence, from the clinical perspective it appears highly desirable that drugs for the treatment of ALI should be effective irrespective of the underlying causes, be they pneumonia, sepsis, acid aspiration or VILI. The identification of common pathways in different experimental models of ALI may help to identify pathways of clinical and therapeutic interest. Therefore, in the present review we have screened the literature for mechanisms that are shared in different models of ALI. Here we have focused on direct ALI, because it may represent a separate and relevant clinical entity and because commonly studied models of indirect lung injury such as endotoxemia or experimental peritonitis in most cases do only cause mild inflammation ((Matute-Bello et al., 2008); our own experience).

Thus, here we will discuss and compare three widely used models: (a) one based on a biological insult, i.e. instillation of bacterial endotoxins; (b) one based on a chemical insult, i.e. instillation of acid; and (c) one based on a mechanical insult, i.e. injurious ventilation. We only included studies if the mediator or mechanism of interest was studied in at least two of the three animal models listed above. As endpoints, we selected neutrophil sequestration, permeability, hypoxemia (physiological dysfunction) and survival (Table 2).

The focus of this review is not to compare models of acute lung injury (there are recent excellent reviews on that topic (Matute-Bello et al., 2008, Matute-Bello et al., 2011)), but to review the molecular mechanisms that are shared in the three models of direct ALI. It was our aim to collect evidence for the hypothesis that there are common mechanisms for direct ALI.

Section snippets

The models

ALI is a complex inflammatory syndrome that cannot be fully studied in cell culture. Animal models are indispensable in order to understand its pathomechanisms and to develop novel therapies. Ideally, such animal models should be based on the aetiology of the disease and reflect the four clinical criteria mentioned above. However, except for acute onset, these criteria are difficult to determine in small laboratory animals frequently used in such studies. In mice or rats, pulmonary wedge

Common mechanisms

To identify common mechanisms of direct ALI, we have put together studies on those interventions and mechanisms that have been addressed in at least two of the three models in Table 2. This table was the basis for the pathway that is depicted in Fig. 1. In the following, we will briefly discuss some of these mechanisms in more detail.

Concluding remarks

It is one premise of this review that a pathway is promising as a drug target for ARDS if its role has been unequivocally shown in several models of the disease. We focused on direct ALI, a field where the majority of experimental studies is concerned with inflammatory pathways. Such studies may have two kinds of implications, mechanistic and clinical. The validity of the clinical conclusions depends on the clinical relevance of the models studied. As can be seen from Table 2, in the majority

Acknowledgement

This study was supported as TP C16 within the SFB 542 from the Deutsche Forschungsgemeinschaft (Bonn, Germany).

References (180)

  • E. Abraham et al.

    HMG-1 as a mediator of acute lung inflammation

    J. Immunol.

    (2000)
  • G.M. Albaiceta et al.

    Absence or inhibition of matrix metalloproteinase-8 decreases ventilator-induced lung injury

    Am. J. Respir. Cell Mol. Biol.

    (2010)
  • U. Andersson et al.

    HMGB1 is a therapeutic target for sterile inflammation and infection

    Annu. Rev. Immunol.

    (2011)
  • ARDSNet

    Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network

    N. Engl. J. Med.

    (2000)
  • E. Azoulay et al.

    Deterioration of previous acute lung injury during neutropenia recovery

    Crit. Care Med.

    (2002)
  • B. Beck-Schimmer et al.

    Expression of lung vascular and airway ICAM-1 after exposure to bacterial lipopolysaccharide

    Am. J. Respir. Cell Mol. Biol.

    (1997)
  • B. Beck-Schimmer et al.

    Pulmonary aspiration: new therapeutic approaches in the experimental model

    Anesthesiology

    (2005)
  • J.A. Belperio et al.

    Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury

    J. Clin. Invest.

    (2002)
  • B.L. Bennett

    c-Jun N-terminal kinase-dependent mechanisms in respiratory disease

    Eur. Respir. J.

    (2006)
  • G.R. Bernard et al.

    The American–European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination

    Am. J. Respir. Crit. Care Med.

    (1994)
  • B. Beutler et al.

    Innate immune sensing and its roots: the story of endotoxin

    Nat. Rev. Immunol.

    (2003)
  • M.E. Bianchi

    DAMPs, PAMPs and alarmins: all we need to know about danger

    J. Leukoc. Biol.

    (2007)
  • K.L. Brigham et al.

    Endotoxin and lung injury

    Am. Rev. Respir. Dis.

    (1986)
  • K. Buttenschoen et al.

    Endotoxemia and endotoxin tolerance in patients with ARDS

    Langenbecks Arch. Surg.

    (2008)
  • P. Caironi et al.

    5-Lipoxygenase deficiency prevents respiratory failure during ventilator-induced lung injury

    Am. J. Respir. Crit. Care Med.

    (2005)
  • S.W. Chang

    TNF potentiates PAF-induced pulmonary vasoconstriction in the rat: role of neutrophils and thromboxane A2

    J. Appl. Physiol.

    (1994)
  • C.M. Chen et al.

    Captopril decreases plasminogen activator inhibitor-1 in rats with ventilator-induced lung injury

    Crit. Care Med.

    (2008)
  • C.H. Chiang et al.

    Correlation between cardiopulmonary changes and severity of acute lung injury in dogs

    Crit. Care Med.

    (1990)
  • M. Chignard et al.

    Neutrophil recruitment and increased permeability during acute lung injury induced by lipopolysaccharide

    Am. J. Physiol. Lung Cell Mol. Physiol.

    (2000)
  • J. Chong et al.

    Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease

    Cochrane Database Syst. Rev.

    (2011)
  • B.W. Christman et al.

    Antilipid mediator and antioxidant therapy in adult respiratory distress syndrome

    New Horiz.

    (1993)
  • R.E. Cilley et al.

    Lung injury produced by moderate lung overinflation in rats

    J. Pediatr. Surg.

    (1993)
  • M. Damarla et al.

    Mitogen activated protein kinase activated protein kinase 2 regulates actin polymerization and vascular leak in ventilator associated lung injury

    PLoS One

    (2009)
  • S.G. Dastidar et al.

    Therapeutic benefit of PDE4 inhibitors in inflammatory diseases

    Curr. Opin. Investig. Drugs

    (2007)
  • B.A. Davidson et al.

    The role of tumor necrosis factor-alpha in the pathogenesis of aspiration pneumonitis in rats

    Anesthesiology

    (1999)
  • T. Dolinay et al.

    Mitogen-activated protein kinases regulate susceptibility to ventilator-induced lung injury

    PLoS One

    (2008)
  • H. Dombrowsky et al.

    Steroids and histone deacetylase in ventilation-induced gene transcription

    Eur. Respir. J.

    (2007)
  • H. Eutamene et al.

    LPS-induced lung inflammation is linked to increased epithelial permeability: role of MLCK

    Eur. Respir. J.

    (2005)
  • F.G. Eyal et al.

    Reduction in alveolar macrophages attenuates acute ventilator induced lung injury in rats

    Intensive Care Med.

    (2007)
  • D.S. Faffe et al.

    Respiratory effects of lipopolysaccharide-induced inflammatory lung injury in mice

    Eur. Respir. J.

    (2000)
  • V. Fanelli et al.

    Pulmonary-derived phosphoinositide 3-kinase gamma (PI3Kgamma) contributes to ventilator-induced lung injury and oedema

    Intensive Care Med.

    (2010)
  • H.G. Folkesson et al.

    Acid aspiration-induced lung injury in rabbits is mediated by interleukin-8-dependent mechanisms

    J. Clin. Invest.

    (1995)
  • J.A. Frank et al.

    Alveolar macrophages contribute to alveolar barrier dysfunction in ventilator-induced lung injury

    Am. J. Physiol. Lung Cell Mol. Physiol.

    (2006)
  • C.W. Frevert et al.

    Functional characterization of the rat chemokine KC and its importance in neutrophil recruitment in a rat model of pulmonary inflammation

    J. Immunol.

    (1995)
  • S. Fujishima et al.

    Neutrophil-mediated tissue injury and its modulation

    Intensive Care Med.

    (1995)
  • A. Funda et al.

    The effects of intratracheal dexamethasone on acute lung injury in rabbits – experimental study

    Middle East. J. Anesthesiol.

    (2005)
  • G. Goldman et al.

    Tumor necrosis factor-alpha mediates acid aspiration-induced systemic organ injury

    Ann. Surg.

    (1990)
  • V. Goncalves de Moraes et al.

    Effect of cyclo-oxygenase inhibitors and modulators of cyclic AMP formation on lipopolysaccharide-induced neutrophil infiltration in mouse lung

    Br. J. Pharmacol.

    (1996)
  • Q. Gong et al.

    Protective effect of antagonist of high-mobility group box 1 on lipopolysaccharide-induced acute lung injury in mice

    Scand. J. Immunol.

    (2009)
  • B.P. Guery et al.

    Ventilation-induced lung injury is associated with an increase in gut permeability

    Shock

    (2003)
  • Cited by (136)

    View all citing articles on Scopus
    View full text